This requirement will fund contracted personnel necessary to effectively support OSE staff on various projects identified by OSE to fulfill statutory obligations, user fee commitments, and specific…
Ended Awarded Last action
- Contract number
- 75F40123F19286
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $5,034,659
Award facts
- Contract value 100% obligated
- $5,034,659.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$177,029 | |
| Supplemental Agreement for work within scope | $776,265 | |
| Original award | $4,435,423 |
About this award
The Food and Drug Administration awarded a Blanket Purchase Agreement (BPA) call contract to Brillient Corporation, a minority-owned digital transformation company, on June 15, 2023, with a ceiling value of $5.03 million. This competitive 8(a) set-aside contract was established under the Multiple Award Schedule vehicle to provide professional and technical services personnel who would support FDA's Office of Special Emphasis (OSE) staff on various projects designed to fulfill statutory obligations, user fee commitments, and specific center or agency goals. The contract utilized a labor hours pricing model and was performed in Reston, Virginia.
The contract modification referenced in this award indicates a de-obligation of funds and closeout action, with an ultimate completion date of August 26, 2024. Brillient Corporation, a Subchapter S Corporation with extensive experience supporting federal agencies including the Department of Health and Human Services, Department of Homeland Security, and the National Institutes of Health, brings program management, IT services, engineering, and consulting expertise to this engagement. The company maintains significant federal contract vehicles, including positions on the General Services Administration's OASIS contract, a $999.9 billion multiple award indefinite delivery/indefinite quantity government-wide acquisition contract.
Description
This requirement will fund contracted personnel necessary to effectively support OSE staff on various projects identified by OSE to fulfill statutory obligations, user fee commitments, and specific center or agency goals. The personnel are necessary
Quick answers
Who was awarded contract 75F40123F19286?
75F40123F19286 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on June 15, 2023.
How much is contract 75F40123F19286 worth?
The government has obligated $5,034,659 on 75F40123F19286.
Is contract 75F40123F19286 an order under another contract?
Yes. 75F40123F19286 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19286 competed?
The extent of competition for 75F40123F19286 was full and open competition. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award